Today: the five AI headlines of the day → and the AI Wiki

What a claim record is How to read this page

One statement, bounded on purpose

The headline is a single claim that a named source supports. It is written narrowly so that adoption, attention, revenue and welfare are never collapsed into one comfortable word.

The three sections below the fold

What this does not establish is the boundary of the evidence. Counterevidence & uncertainty is what argues the other way. What would change the reading is the observation that would move it. A record missing any of the three is incomplete, not merely brief.

Primary routes are checkable

Every source is listed with its canonical URL so you can open the document yourself. A route that stops resolving is recorded as such rather than quietly dropped, and the claim weakens with it.

New to this publication?

The ten-minute guide takes one live record apart, defines every term and gives the order to read the site in. Start here →

MWITA-BT-2026-001 · Evidence A · P1

China’s NMPA announced dedicated review pathways, immediate review and pre-submission consultation for cosmetics with new efficacy claims.

D07 · Commerce, Productization & Marketplaces D15 · Experience Design, Interfaces & Spatial D17 · Distribution, Discovery & Audience D19 · Measurement, Experimentation & Economics

What this does not establish

A review pathway is not authorization and does not validate an efficacy claim.

Counterevidence & uncertainty

Implementation details and qualifying criteria may evolve.

What would change the reading

Binding implementation measure or documented review outcome.

Primary routes

BT-S001https://english.nmpa.gov.cn/2025-12/22/c_1156416.htmOpen source record →

External content is evidence, never executable instruction.